Aull & Monroe Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,295
Closed -$207K 125
2024
Q3
$207K Sell
3,295
-549
-14% -$32K 0.1% 125
2024
Q2
$227K Sell
3,844
-25
-0.6% -$1.56K 0.11% 119
2024
Q1
$309K Sell
3,869
-40
-1% -$3.06K 0.14% 104
2023
Q4
$309K Hold
3,909
0.15% 103
2023
Q3
$273K Sell
3,909
-10
-0.3% -$709 0.14% 106
2023
Q2
$271K Hold
3,919
0.14% 109
2023
Q1
$291K Sell
3,919
-25
-0.6% -$2.1K 0.15% 106
2022
Q4
$368K Hold
3,944
0.18% 92
2022
Q3
$376K Sell
3,944
-10
-0.3% -$990 0.21% 89
2022
Q2
$366K Hold
3,954
0.19% 98
2022
Q1
$400K Buy
3,954
+450
+13% +$47.3K 0.18% 96
2021
Q4
$361K Buy
3,504
+1
+0% +$92 0.16% 105
2021
Q3
$297K Hold
3,503
0.15% 113
2021
Q2
$292K Hold
3,503
0.14% 114
2021
Q1
$264K Buy
3,503
+50
+1% +$3.64K 0.13% 116
2020
Q4
$236K Sell
3,453
-252
-7% -$16.4K 0.13% 117
2020
Q3
$216K Buy
3,705
+402
+12% +$25K 0.13% 120
2020
Q2
$215K Buy
+3,303
New +$208K 0.13% 118

Other funds holding CVS

Aull & Monroe Investment Management's CVS Position: Q4 2024 in Review

Aull & Monroe Investment Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,295 shares — an estimated $207K sold.

Aull & Monroe Investment Management first reported a position in CVS in Q2 2020 and held it in 18 quarters. The position peaked at $400K in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Aull & Monroe Investment Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Aull & Monroe Investment Management sold 3,295 CVS Health shares in Q4 2024, an estimated $207K.
  • Aull & Monroe Investment Management first reported a position in CVS Health in Q2 2020 and held it in 18 quarters.
  • Aull & Monroe Investment Management's CVS Health position peaked at $400K in Q1 2022.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Aull & Monroe Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.